Taimei Technology and C&R Research Announce Strategic Partnership to Build AI-Powered Clinical Trial Innovation
SEOUL, South Korea and SHANGHAI, May 7, 2026 /PRNewswire/ -- Taimei Technology (HK.02576), a leading AI-powered drug clinical development platform company, and C&R Research (A359090), a top-tier CRO in South Korea, signed an enterprise-level...
Taimei Technology Debuts at BioKorea 2026, Showcasing AI-Powered Clinical Research Solutions
SEOUL, South Korea, April 30, 2026 /PRNewswire/ -- Taimei Technology, a leading AI-driven drug clinical development platform, made its first public appearance in South Korea at BioKorea 2026, drawing significant attention with its advanced...